Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Oct 2006 07:00 AM
RNS
Gene Therapy for Blindness
25 Sep 2006 02:32 PM
RNS
Holding(s) in Company
20 Sep 2006 10:08 AM
RNS
Holding(s) in Company
07 Sep 2006 10:54 AM
RNS
Interest in Share Options
05 Sep 2006 07:01 AM
RNS
SWOG in phase 2 Trovax trial
05 Sep 2006 07:00 AM
RNS
Interim Results
21 Aug 2006 07:00 AM
RNS
Trovax at Cancer Conference
03 Aug 2006 04:00 PM
RNS
Holding(s) in Company
02 Aug 2006 07:00 AM
RNS
Notice of Interim Results
31 Jul 2006 07:00 AM
RNS
Trovax Update & Clarification
18 Jul 2006 04:09 PM
RNS
Holding(s) in Company
06 Jul 2006 04:31 PM
RNS
Holding(s) in Company
05 Jul 2006 04:54 PM
RNS
Director/PDMR Shareholding
26 Jun 2006 11:43 AM
RNS
Holding(s) in Company
26 Jun 2006 07:00 AM
RNS
Prosavin Patent
21 Jun 2006 07:00 AM
RNS
Piper Jaffray Health Care
14 Jun 2006 07:00 AM
RNS
SUIT AGAINST OPEN BIOSYSTEMS
12 Jun 2006 04:00 PM
RNS
Holding(s) in Company
07 Jun 2006 07:00 AM
RNS
Phase II results - TROVAX
23 May 2006 07:00 AM
RNS
Phase II Trial Trovax
22 May 2006 04:30 PM
RNS
Holding(s) in Company
18 May 2006 07:00 AM
RNS
Blocklisting Interim Review
16 May 2006 08:51 AM
RNS
Director/PDMR Shareholding
12 May 2006 07:00 AM
RNS
Agreement with FDA
04 May 2006 11:53 AM
RNS
Annual General Meeting 06
02 May 2006 07:01 AM
RNS
RETINOSTAT
20 Apr 2006 05:38 PM
RNS
Holding(s) in Company
11 Apr 2006 04:26 PM
RNS
Annual Report and Accounts
11 Apr 2006 08:21 AM
RNS
Annual Information Update
06 Apr 2006 01:23 PM
RNS
Holding(s) in Company
30 Mar 2006 07:01 AM
RNS
Clinical Trial Results
24 Mar 2006 12:40 PM
RNS
Holding(s) in Company
23 Mar 2006 11:03 AM
RNS
Director/PDMR Shareholding
16 Mar 2006 04:04 PM
RNS
Director/PDMR Shareholding
14 Mar 2006 07:00 AM
RNS
Preliminary Results
10 Mar 2006 07:00 AM
RNS
VIRxSYS Corporation Licence
23 Feb 2006 07:00 AM
RNS
Notice of Results
03 Feb 2006 09:48 AM
RNS
Board Appointment
26 Jan 2006 09:46 AM
RNS
Holding(s) in Company
24 Jan 2006 08:44 AM
RNS
Holding(s) in Company
18 Jan 2006 04:13 PM
RNS
Viragen Milestone
04 Jan 2006 10:12 AM
RNS
Holding(s) in Company
20 Dec 2005 04:42 PM
RNS
Holding(s) in Company
19 Dec 2005 05:10 PM
RNS
Holding in Company Correction
19 Dec 2005 04:55 PM
RNS
Holding(s) in Company
19 Dec 2005 11:07 AM
RNS
Holding(s) in Company
16 Dec 2005 01:45 PM
RNS
Director/PDMR S/hldg-Amend
16 Dec 2005 08:23 AM
RNS
Director/PDMR Shareholding
15 Dec 2005 09:00 AM
RNS
Director/PDMR Shareholding
12 Dec 2005 12:34 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings